Early Diagnosis Of Childhood Cerebral ALD

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2018-11-30

Study Completion Date

2023-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this single institution study is to evaluate boys with adrenoleukodystrophy (ALD) diagnosed early in life, and to prospectively monitor them to determine parameters that will facilitate earlier detection of the childhood cerebral form of the disease. These at-risk subjects will be assessed yearly through travel to the University of Minnesota, where plasma and cerebral spinal fluid (CSF) biomarker studies, MRI based imaging and neuropsychological assessments will be performed at the University of Minnesota Masonic Children's Hospital and Clinics. The MRI and lumbar puncture to obtain CSF will be obtained under sedation. In addition, at intervening 6 months intervals information will be obtained remotely, including surveys and MRI's in their home location. Also at that time blood samples will be obtained locally and shipped to the University of Minnesota for study. There is no therapeutic intent in this study.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Cerebral Blood Flow in Single Ventricles Throughout Staged Surgical Reconstruction

NCT02135081

Single Ventricle Defect

COMPLETED

Allogeneic hMSC Injection in Patients With Hypoplastic Left Heart Syndrome

NCT02398604

Hypoplastic Left Heart Syndrome

TERMINATED PHASE1

Observational Study of Males With Creatine Transporter Deficiency

NCT02931682

Creatine Deficiency, X-linked

TERMINATED

Study of Skeletal Disorders

NCT05031507

Skeletal Disorders

RECRUITING

Testicular Adrenal Rest Tumor in Congenital Adrenal Hyperplasia Patients Attending Assuit University Children Hospital

NCT06564220

Testicular Adrenal Rest Tumor Congenital Adrenal Hyperplasia

NOT_YET_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Adrenoleukodystrophy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Boys with confirmed adrenoleukodystrophy, as determined by very long chain fatty acid (VLCFA) analysis and/or genotyping. Genotyping is not necessary for diagnosis.
* Between 1 and 5 years of age, inclusive at the time of consent.
* Able to undergo a sedation
* English as primary language of the household, to maximize consistency of the neuropsychological/developmental testing.
* Voluntary written parental/guardian consent

Exclusion Criteria

* Evidence of cerebral disease at time of enrollment - patients over 3 years of age must have an MRI within 4 months of signing consent to confirm that there is no evidence of cerebral disease
* Inability or unwillingness to travel to the University of Minnesota once a year for the duration of the study
* Evidence of cerebral disease by standard T2/FLAIR MRI. If a subject develops cerebral ALD during the study, they will come off study, as it is anticipated that they would be considered for transplantation.

Minimum Eligible Age

1 Year

Maximum Eligible Age

5 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No